Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-25-020083
Filing Date
2025-10-29
Accepted
2025-10-29 16:30:38
Documents
20
Period of Report
2025-10-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A formdef14a.htm   iXBRL DEF 14A 1062263
2 GRAPHIC formdef14a_001.jpg GRAPHIC 7719
3 GRAPHIC formdef14a_002.jpg GRAPHIC 10417
4 GRAPHIC proxycard_001.jpg GRAPHIC 814659
5 GRAPHIC proxycard_002.jpg GRAPHIC 1098765
  Complete submission text file 0001493152-25-020083.txt   6885430

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE aimi-20241231.xsd EX-101.SCH 8559
7 XBRL DEFINITION FILE aimi-20241231_def.xml EX-101.DEF 12223
8 XBRL LABEL FILE aimi-20241231_lab.xml EX-101.LAB 76183
9 XBRL PRESENTATION FILE aimi-20241231_pre.xml EX-101.PRE 46162
23 EXTRACTED XBRL INSTANCE DOCUMENT formdef14a_htm.xml XML 194380
Mailing Address 2117 SW HIGHWAY 484 OCALA FL 32801
Business Address 2117 SW HIGHWAY 484 OCALA FL 32801 352-448-7797
AIM ImmunoTech Inc. (Filer) CIK: 0000946644 (see all company filings)

EIN.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-27072 | Film No.: 251430441
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)